GLPIX
Price
$41.73
Change
-$0.15 (-0.36%)
Updated
Jul 6 closing price
Net Assets
1.81B
PRPQX
Price
$7.11
Change
-$0.01 (-0.14%)
Updated
Jul 6 closing price
Net Assets
555.54M
Interact to see
Advertisement

GLPIX vs PRPQX

GLPIX vs PRPQX Comparison Chart in %
View a ticker or compare two or three
VS
GLPIX vs. PRPQX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPIX is a Buy and PRPQX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GLPIX has more cash in the bank: 1.81B vs. PRPQX (556M). PRPQX pays higher dividends than GLPIX: PRPQX (8.98) vs GLPIX (6.38). GLPIX was incepted earlier than PRPQX: GLPIX (13 years) vs PRPQX (8 years). GLPIX (1.17) is less costly to investors than PRPQX (1.11). GLPIX is a more actively managed with annual turnover of: 130.00 vs. PRPQX (21.00). GLPIX (0) and PRPQX (0) have matching initial minimum investment requirements. PRPQX annual gain was more profitable for investors over the last year : 23.42 vs. GLPIX (18.23). GLPIX return over 5 years is better than : 139.21 vs. PRPQX (122.96).
GLPIXPRPQXGLPIX / PRPQX
Total Expense Ratio1.171.11105%
Annual Report Gross Expense Ratio1.171.11105%
Fund Existence13 years8 years-
Gain YTD17.39319.88787%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.81B556M326%
Annual Yield % from dividends6.388.9871%
Returns for 1 year18.2323.4278%
Returns for 3 years76.5383.0092%
Returns for 5 years139.21122.96113%
Returns for 10 years102.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VIOG152.091.17
+0.78%
Vanguard S&P Small-Cap 600 Growth ETF
APRH25.010.05
+0.20%
Innovator Premium Income 20 Bar ETF -Apr
SEPM32.85N/A
N/A
FT Vest U.S. Eq Max Buffr ETF - Sep
IMST7.64-0.02
-0.26%
Bitwise MSTR Option Income Strategy ETF
IDNA34.68-0.23
-0.66%
iShares Genomics Immnlgy & Hlthcr ETF